Biotech Blog Archives: July 2007
next page ·
26 July 2007
Expanding the bandwidth of life science investments: Increasing investment viability
Guest content Contributed by Jayme Norrie, Chief Strategic Officer, Incite World
From what we have experienced, angel investors are shoring up the gap in new innovations coming forward. However, they seem to be more naive than VC’s in terms of due diligence prior to investing. Scientists from the company march in with charts and scientific graphs [...]
continue reading... » 2 Comments
24 July 2007
Call for Papers: Journal of Commercial Biotechnology
The Journal of Commercial Biotechnology is looking for some fresh voices.
Journal of Commercial Biotechnology is an international peer-reviewed, professional journal which focuses on the commercial, legal and regulatory issues affecting biotech, biopharmaceutical, agrochemical and environmental companies. Organizations whose representatives have demonstrated their expertise in recent issues include Genzyme, Merck, GlaxoSmithKline, KPMG, Ernst & Young, [...]
continue reading... » 0 Comments
23 July 2007
Offshoring and U.S. Biotech Labor Shortages
Contributed by Agnes Shanley, Editor in Chief, Pharmaceutical Manufacturing
Every day we read about severe shortages of skilled biotech workers in the U.S.. At the same time, the trend to pharma offshoring and outsourcing is becoming more pronounced, and is moving from traditional pharma to biopharma.
We recently touched on some of these issues in Pharmaceutical Manufacturing. [...]
continue reading... » 2 Comments
19 July 2007
`Til Death Do Us Part, But First, the Pre-Nup: Why CAPA Needs to Evolve
A guest editorial from Emil Ciurczak, Contributing Editor, PharmaManufacturing.com
While reading a trade magazine recently, I was struck with the detailed information on how to design and implement a Corrective and Preventive Action (CAPA) system. ISO 9001:200, Clause 8.5.2 states, “…the organization shall take action to eliminate the cause of nonconformities encountered…” For medical devices, 21 [...]
continue reading... » 5 Comments
12 July 2007
Drug reimportation: Where are the dead Canadians?
A common retort in the debate over drug reimportation is “Where are the dead Canadians?”
If the FDA deems that import of drugs from Canada is potentially dangerous, why aren’t Canadians dying from drugs they buy in Canada? Well, there’s an answer to that: Most Canadians buy their drugs from drugstores, not over the Internet. Individuals [...]
continue reading... » 2 Comments
11 July 2007
Starting a biotechnology company to treat a child
CnnMoney has a cool story on a mother who was motivated to start a biotech company to develop a better treatment for her daughter’s disease. A former lawyer and founder of satellite-communications companies including Sirius Satellite Radio, Martine Rothblatt was able to develop proficiency in biotechnology and her company, United Therapeutics, grossed $159 million in [...]
